Elsevier Announces New Editor-in-Chief of Trends in Cardiovascular Medicine
Douglas P. Zipes, M.D.
Douglas P. Zipes, M.D.
Philadelphia, March 19, 2014
Douglas P. Zipes, M.D., has been named the new Editor-in-Chief of Trends in Cardiovascular Medicine, Elsevier announced today. Dr. Zipes will succeed Elizabeth Nabel, M.D., who has served as Editor-in-Chief since 2004.
Douglas P. Zipes, M.D., serves as a Distinguished Professor at the Krannert Institute of Cardiology at Indiana University. He has also held other positions at Indiana University, including Professor of Medicine, Pharmacology and Toxicology in 1994 and Director of the Cardiology Division at the Krannert Institute of Cardiology.
Dr. Zipes received his B.A. cum laude from Dartmouth College, his M.D. cum laude from Harvard Medical School, and his postgraduate training at Duke University Medical Center. A past chairman of the American Board of Internal Medicine, he is the past president of several professional organizations, including the Cardiac Electrophysiology Society, the Association of University Cardiologists, the Heart Rhythm Society, and the American College of Cardiology.
Dr. Zipes is a specialist on the research and treatment of cardiac arrhythmias and led the team that developed the very first implantable cardioverter. Among many contributions, he pioneered an alcohol ablation catheterization technique that cures some arrhythmias and is a specialist in many arrhythmia areas, including sudden death.
Dr. Zipes was the founding editor of HeartRhythm; is the editor of Elsevier’s Practice Update: Cardiology; and has authored over 800 articles and 24 textbooks, including Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, Cardiac Electrophysiology: From Cell to Bedside, Clinical Arrhythmology and Electrophysiology, and Electrocardiography of Arrhythmias. In addition, he writes a regular column for the Saturday Evening Post called “Heart Health: Ask Dr. Zipes.”
Dr. Zipes stated, “I am honored to become editor of TCM. It is my goal to make it a valuable addition to the educational choices for clinicians and basic scientists in cardiology. A unique feature will be to link PracticeUpdate/Cardiology and Braunwald’s Heart Disease in this educational effort.”
Trends in Cardiovascular Medicine provides in-depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+1 215 239 3704